Elder Pharmaceuticals Ltd

Elder Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Elder Pharmaceuticals Ltd

₹ 38.0 4.97%
12 Sep 2016
elderindia.com
About

Elder Pharmaceuticals Limited, incorporated in India, listed on the Bombay Stock Exchange Limited, and National Stock Exchange Limited, the company is engaged in deals in pharmaceuticals & related products

[ add key points ]
Website
  • Market Cap ₹ 78.0 Cr.
  • Current Price ₹ 38.0
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ 342
  • Dividend Yield 0.00 %
  • ROCE -3.56 %
  • ROE -45.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Stock is trading at 0.11 times its book value
  • Debtor days have improved from 81.3 to 60.7 days.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 9.95% over past five years.
  • Company has a low return on equity of -9.04% over last 3 years.
  • Contingent liabilities of Rs.161 Cr.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014 Mar 2015
323 185 273 387 229 120 203 158 152
283 128 229 354 240 637 233 188 164
Operating Profit 40 57 44 34 -11 -517 -30 -31 -12
OPM % 12% 31% 16% 9% -5% -430% -15% -19% -8%
17 -1 6 4 19 740 17 1 2
Interest 23 48 37 49 69 120 23 45 22
Depreciation 9 8 9 11 10 6 11 9 10
Profit before tax 26 1 4 -23 -72 96 -47 -84 -43
Tax % 20% -4% 29% 1% 2% -0% 0% 0% 7%
21 1 3 -23 -74 97 -47 -84 -46
EPS in Rs 10.22 0.41 1.53 -11.36 -35.85 47.01 -22.82 -40.69 -22.41
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Jun 2013 15m Jun 2014 TTM
449 551 620 722 960 1,329 1,626 997 633
371 446 538 599 789 1,130 1,354 1,433 1,222
Operating Profit 78 105 82 123 171 199 272 -436 -589
OPM % 17% 19% 13% 17% 18% 15% 17% -44% -93%
7 8 41 4 4 28 31 754 760
Interest 16 24 41 53 66 102 155 276 211
Depreciation 9 11 12 17 29 34 44 36 37
Profit before tax 61 79 70 57 80 92 104 6 -77
Tax % 14% 11% 13% 16% 21% 21% 21% 209%
53 70 61 47 64 72 82 -7 -80
EPS in Rs 28.41 37.10 32.26 26.25 31.27 35.19 40.12 -3.18 -38.91
Dividend Payout % 9% 7% 8% 11% 10% 9% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 10%
3 Years: 1%
TTM: -41%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -390%
Stock Price CAGR
10 Years: 1%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: -2%
3 Years: -9%
Last Year: -46%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Jun 2013 Jun 2014
Equity Capital 19 19 19 19 21 21 21 21
Reserves 305 346 373 462 610 680 749 753
237 342 499 574 832 1,081 1,344 848
113 91 122 138 279 219 380 667
Total Liabilities 673 798 1,013 1,192 1,741 2,000 2,492 2,288
140 169 171 490 648 706 691 707
CWIP 137 163 252 66 95 191 273 305
Investments 37 88 50 66 10 20 3 3
359 377 539 570 989 1,082 1,526 1,273
Total Assets 673 798 1,013 1,192 1,741 2,000 2,492 2,288

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Jun 2013 Jun 2014
71 21 136 -91 66 15 17 1,175
-88 -108 -35 -161 -151 -171 -63 -56
38 110 -34 184 273 43 -4 -676
Net Cash Flow 20 22 67 -68 188 -113 -51 443
Free Cash Flow -30 -44 34 -241 -149 -171 -95 1,096
CFO/OP 91% 29% 177% -66% 49% 18% 15% -272%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Jun 2013 Jun 2014
Debtor Days 99 92 105 99 107 94 89 61
Inventory Days 154 115 107 151 189 155 107 73
Days Payable 65 45 39 40 37 47 53 55
Cash Conversion Cycle 189 162 172 210 259 202 144 79
Working Capital Days 158 140 163 186 112 140 93 -97
ROCE % 16% 12% 12% 12% 12% 13% -4%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

Annual reports